Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Nine In Ten Survive Early Stage Bowel Cancer
Nine in ten people with bowel cancer that is caught early will survive the disease, according to new statistics published today (Tuesday).
generic viagra online
Is There Long-Term Brain Damage After Bypass Surgery? More Evidence Puts The Blame On Heart Disease
Brain scientists and cardiac surgeons at Johns Hopkins have evidence from 227 heart bypass surgery patients that long-term memory losses and cognitive problems they experience are due to the underlying coronary artery disease itself and not ill after-effects from having used a heart-lung machine.
News of the day
New Results In Fight Against Blindness Revealed
The CARMA Study Group, representing leading researchers at Queens University, Belfast and the Waterford Institute of Technology will unveil the results of a 5 year project into age-related macular degeneration (AMD) on Friday, 19th June at 2pm in the Radisson Hotel, Belfast. AMD is the leading cause of blindness in the Western world*1.
Oncology

Clinical Study Shows Value Of Nexstim's Navigated Brain Stimulation (NBS) In Eloquent Cortex Surgery

Nexstim Oy, a medical device company developing non-invasive brain diagnostics and therapy technologies, announces presentation of the abstract "TMS as a part of multimodal management of safe glioma resection in the motor cortex" at the 60th Annual Meeting of the German Society of Neurosurgery. Clinicians at the distinguished Department of Neurosurgery, Johann Wolfgang Goethe-University, Frankfurt, Germany compared the results of non-invasive TMS, using Nexstim"s Navigated Brain Stimulation (NBS) System, and fMRI with the results of invasive direct cortical stimulation (DCS) in patients with tumors in or near the motor cortex. The clinicians noted that in all patients "TMS showed congruence with DCS. In contrast to fMRI, TMS and DCS enabled identification of eloquent cortex within the tumor." In addition, the Frankfurt clinicians concluded that "TMS (as part of Nexstim"s NBS System) may call into question categorizing tumors in the motor cortex as unresectable, since TMS anticipates information usually only enabled by invasive DCS." Abstract: click here. Jukka-Pekka Sç¤rkkç¤, Managing Director of Nexstim commented, "The Frankfurt study confirms our belief that NBS overcomes the limitations of fMRI and we were pleased with the enormous interest in NBS at this important meeting." About NBS in neurosurgery Unlike functional magnetic resonance imaging (fMRI), NBS is a direct method, like DCS, for accurate mapping of the cerebral cortex. DCS is considered the gold standard but it is an invasive technique and can require a large, awake craniotomy. Accurate presurgical maps of the vital functional areas of the cortex, enabled by NBS, allow selection of the optimal treatment strategy for the individual patient, they also save valuable time in the OR and have the potential to enable better patient outcomes. NBS System is CE-marked. Caution: in the United States the NBS System is limited by Federal law to investigational use. Nexstim


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009